Global Genitourinary Drugs Sales Market Report 2017

February 2017 | 128 pages | ID: G9E8F9C9417EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Genitourinary Drugs

Revenue, means the sales value of Genitourinary Drugs

This report studies sales (consumption) of Genitourinary Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Astellas
• Pfizer
• GlaxoSmithKline
• Eli Lilly
• Bayer AG
• Merck
• Abbott Laboratories
• Bristol-Myers Squibb
• Genentech
• Roche
• Amgen
• Botex

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Genitourinary Drugs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Sex Hormones
• Urologicals
• Genitourinary Anti-Infectives
• Gynaecologicals

Split by applications, this report focuses on sales, market share and growth rate of Genitourinary Drugs in each application, can be divided into

• Genitourinary Cancer
• Bladder Cancer
• Cervical Cancer
• Kidney/Renal Cancer
• Ovarian Cancer
• Prostate Cancer

Contents

Global Genitourinary Drugs Sales Market Report 2017

1 GENITOURINARY DRUGS OVERVIEW

1.1 Product Overview and Scope of Genitourinary Drugs
1.2 Classification of Genitourinary Drugs
  1.2.1 Sex Hormones
  1.2.2 Urologicals
  1.2.3 Genitourinary Anti-Infectives
  1.2.4 Gynaecologicals
1.3 Application of Genitourinary Drugs
  1.3.1 Genitourinary Cancer
  1.3.2 Bladder Cancer
  1.3.3 Cervical Cancer
  1.3.4 Kidney/Renal Cancer
  1.3.5 Ovarian Cancer
  1.3.6 Prostate Cancer
1.4 Genitourinary Drugs Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Genitourinary Drugs (2012-2022)
  1.5.1 Global Genitourinary Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Genitourinary Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL GENITOURINARY DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Genitourinary Drugs Market Competition by Manufacturers
  2.1.1 Global Genitourinary Drugs Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Genitourinary Drugs Revenue and Share by Manufacturers (2012-2017)
2.2 Global Genitourinary Drugs (Volume and Value) by Type
  2.2.1 Global Genitourinary Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Genitourinary Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Genitourinary Drugs (Volume and Value) by Regions
  2.3.1 Global Genitourinary Drugs Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Genitourinary Drugs Revenue and Market Share by Regions (2012-2017)
2.4 Global Genitourinary Drugs (Volume) by Application

3 UNITED STATES GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Genitourinary Drugs Sales and Value (2012-2017)
  3.1.1 United States Genitourinary Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Genitourinary Drugs Sales Price Trend (2012-2017)
3.2 United States Genitourinary Drugs Sales and Market Share by Manufacturers
3.3 United States Genitourinary Drugs Sales and Market Share by Type
3.4 United States Genitourinary Drugs Sales and Market Share by Application

4 CHINA GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Genitourinary Drugs Sales and Value (2012-2017)
  4.1.1 China Genitourinary Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Genitourinary Drugs Sales Price Trend (2012-2017)
4.2 China Genitourinary Drugs Sales and Market Share by Manufacturers
4.3 China Genitourinary Drugs Sales and Market Share by Type
4.4 China Genitourinary Drugs Sales and Market Share by Application

5 EUROPE GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Genitourinary Drugs Sales and Value (2012-2017)
  5.1.1 Europe Genitourinary Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Genitourinary Drugs Sales Price Trend (2012-2017)
5.2 Europe Genitourinary Drugs Sales and Market Share by Manufacturers
5.3 Europe Genitourinary Drugs Sales and Market Share by Type
5.4 Europe Genitourinary Drugs Sales and Market Share by Application

6 JAPAN GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Genitourinary Drugs Sales and Value (2012-2017)
  6.1.1 Japan Genitourinary Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Genitourinary Drugs Sales Price Trend (2012-2017)
6.2 Japan Genitourinary Drugs Sales and Market Share by Manufacturers
6.3 Japan Genitourinary Drugs Sales and Market Share by Type
6.4 Japan Genitourinary Drugs Sales and Market Share by Application

7 SOUTHEAST ASIA GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Genitourinary Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Genitourinary Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Genitourinary Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Genitourinary Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Genitourinary Drugs Sales and Market Share by Type
7.4 Southeast Asia Genitourinary Drugs Sales and Market Share by Application

8 INDIA GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Genitourinary Drugs Sales and Value (2012-2017)
  8.1.1 India Genitourinary Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Genitourinary Drugs Sales Price Trend (2012-2017)
8.2 India Genitourinary Drugs Sales and Market Share by Manufacturers
8.3 India Genitourinary Drugs Sales and Market Share by Type
8.4 India Genitourinary Drugs Sales and Market Share by Application

9 GLOBAL GENITOURINARY DRUGS MANUFACTURERS ANALYSIS

9.1 Astellas
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Genitourinary Drugs Product Type, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Pfizer
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Genitourinary Drugs Product Type, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 GlaxoSmithKline
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Genitourinary Drugs Product Type, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Eli Lilly
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Genitourinary Drugs Product Type, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Bayer AG
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Genitourinary Drugs Product Type, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Merck
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Genitourinary Drugs Product Type, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Abbott Laboratories
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Genitourinary Drugs Product Type, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Bristol-Myers Squibb
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Genitourinary Drugs Product Type, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Genentech
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Genitourinary Drugs Product Type, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Roche
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Genitourinary Drugs Product Type, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Amgen
9.12 Botex

10 GENITOURINARY DRUGS MAUFACTURING COST ANALYSIS

10.1 Genitourinary Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Genitourinary Drugs
10.3 Manufacturing Process Analysis of Genitourinary Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Genitourinary Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL GENITOURINARY DRUGS MARKET FORECAST (2017-2022)

14.1 Global Genitourinary Drugs Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Genitourinary Drugs Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Genitourinary Drugs Price and Trend Forecast (2017-2022)
14.2 Global Genitourinary Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Genitourinary Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Genitourinary Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Genitourinary Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Genitourinary Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Genitourinary Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Genitourinary Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Genitourinary Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Genitourinary Drugs Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Genitourinary Drugs
Table Classification of Genitourinary Drugs
Figure Global Sales Market Share of Genitourinary Drugs by Type in 2015
Figure Sex Hormones Picture
Figure Urologicals Picture
Figure Genitourinary Anti-Infectives Picture
Figure Gynaecologicals Picture
Table Applications of Genitourinary Drugs
Figure Global Sales Market Share of Genitourinary Drugs by Application in 2015
Figure Genitourinary Cancer Examples
Figure Bladder Cancer Examples
Figure Cervical Cancer Examples
Figure Kidney/Renal Cancer Examples
Figure Ovarian Cancer Examples
Figure Prostate Cancer Examples
Figure United States Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure China Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure India Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Global Genitourinary Drugs Sales and Growth Rate (2012-2022)
Figure Global Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Table Global Genitourinary Drugs Sales of Key Manufacturers (2012-2017)
Table Global Genitourinary Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Genitourinary Drugs Sales Share by Manufacturers
Figure 2016 Genitourinary Drugs Sales Share by Manufacturers
Table Global Genitourinary Drugs Revenue by Manufacturers (2012-2017)
Table Global Genitourinary Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Genitourinary Drugs Revenue Share by Manufacturers
Table 2016 Global Genitourinary Drugs Revenue Share by Manufacturers
Table Global Genitourinary Drugs Sales and Market Share by Type (2012-2017)
Table Global Genitourinary Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Genitourinary Drugs by Type (2012-2017)
Figure Global Genitourinary Drugs Sales Growth Rate by Type (2012-2017)
Table Global Genitourinary Drugs Revenue and Market Share by Type (2012-2017)
Table Global Genitourinary Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Genitourinary Drugs by Type (2012-2017)
Figure Global Genitourinary Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Genitourinary Drugs Sales and Market Share by Regions (2012-2017)
Table Global Genitourinary Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Genitourinary Drugs by Regions (2012-2017)
Figure Global Genitourinary Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Genitourinary Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Genitourinary Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Genitourinary Drugs by Regions (2012-2017)
Figure Global Genitourinary Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Genitourinary Drugs Sales and Market Share by Application (2012-2017)
Table Global Genitourinary Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Genitourinary Drugs by Application (2012-2017)
Figure Global Genitourinary Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure United States Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure United States Genitourinary Drugs Sales Price Trend (2012-2017)
Table United States Genitourinary Drugs Sales by Manufacturers (2012-2017)
Table United States Genitourinary Drugs Market Share by Manufacturers (2012-2017)
Table United States Genitourinary Drugs Sales by Type (2012-2017)
Table United States Genitourinary Drugs Market Share by Type (2012-2017)
Table United States Genitourinary Drugs Sales by Application (2012-2017)
Table United States Genitourinary Drugs Market Share by Application (2012-2017)
Figure China Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure China Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure China Genitourinary Drugs Sales Price Trend (2012-2017)
Table China Genitourinary Drugs Sales by Manufacturers (2012-2017)
Table China Genitourinary Drugs Market Share by Manufacturers (2012-2017)
Table China Genitourinary Drugs Sales by Type (2012-2017)
Table China Genitourinary Drugs Market Share by Type (2012-2017)
Table China Genitourinary Drugs Sales by Application (2012-2017)
Table China Genitourinary Drugs Market Share by Application (2012-2017)
Figure Europe Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure Europe Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Genitourinary Drugs Sales Price Trend (2012-2017)
Table Europe Genitourinary Drugs Sales by Manufacturers (2012-2017)
Table Europe Genitourinary Drugs Market Share by Manufacturers (2012-2017)
Table Europe Genitourinary Drugs Sales by Type (2012-2017)
Table Europe Genitourinary Drugs Market Share by Type (2012-2017)
Table Europe Genitourinary Drugs Sales by Application (2012-2017)
Table Europe Genitourinary Drugs Market Share by Application (2012-2017)
Figure Japan Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure Japan Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Genitourinary Drugs Sales Price Trend (2012-2017)
Table Japan Genitourinary Drugs Sales by Manufacturers (2012-2017)
Table Japan Genitourinary Drugs Market Share by Manufacturers (2012-2017)
Table Japan Genitourinary Drugs Sales by Type (2012-2017)
Table Japan Genitourinary Drugs Market Share by Type (2012-2017)
Table Japan Genitourinary Drugs Sales by Application (2012-2017)
Table Japan Genitourinary Drugs Market Share by Application (2012-2017)
Figure Southeast Asia Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure Southeast Asia Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Genitourinary Drugs Sales Price Trend (2012-2017)
Table Southeast Asia Genitourinary Drugs Sales by Manufacturers (2012-2017)
Table Southeast Asia Genitourinary Drugs Market Share by Manufacturers (2012-2017)
Table Southeast Asia Genitourinary Drugs Sales by Type (2012-2017)
Table Southeast Asia Genitourinary Drugs Market Share by Type (2012-2017)
Table Southeast Asia Genitourinary Drugs Sales by Application (2012-2017)
Table Southeast Asia Genitourinary Drugs Market Share by Application (2012-2017)
Figure India Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure India Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure India Genitourinary Drugs Sales Price Trend (2012-2017)
Table India Genitourinary Drugs Sales by Manufacturers (2012-2017)
Table India Genitourinary Drugs Market Share by Manufacturers (2012-2017)
Table India Genitourinary Drugs Sales by Type (2012-2017)
Table India Genitourinary Drugs Market Share by Type (2012-2017)
Table India Genitourinary Drugs Sales by Application (2012-2017)
Table India Genitourinary Drugs Market Share by Application (2012-2017)
Table Astellas Basic Information List
Table Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Genitourinary Drugs Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Genitourinary Drugs Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Genitourinary Drugs Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Genitourinary Drugs Global Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer AG Genitourinary Drugs Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Genitourinary Drugs Global Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Genitourinary Drugs Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Genitourinary Drugs Global Market Share (2012-2017)
Table Genentech Basic Information List
Table Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Genitourinary Drugs Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Genitourinary Drugs Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Botex Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genitourinary Drugs
Figure Manufacturing Process Analysis of Genitourinary Drugs
Figure Genitourinary Drugs Industrial Chain Analysis
Table Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
Table Major Buyers of Genitourinary Drugs
Table Distributors/Traders List
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Genitourinary Drugs Sales Forecast by Regions (2017-2022)
Table Global Genitourinary Drugs Sales Forecast by Type (2017-2022)
Table Global Genitourinary Drugs Sales Forecast by Application (2017-2022)